| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Institute of Genetic Medicine [H. C., E. L. N., J. D. R., P. O., S. A. B., A. P. F.] and Departments of Medicine [H. C., A. P. F.], Oncology [A. P. F.], and Molecular Biology and Genetics [A. P. F.], Graduate Programs in Human Genetics [E. L. N.], and Biochemistry, Cell and Molecular Biology [J. D. R.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892 [V. V. L.]
Loss of imprinting (LOI) is the most common molecular abnormality in Wilms tumor (WT), other embryonal cancers, and most other tumor types. LOI in WT involves activation of the normally silent maternal allele of the insulin-like growth factor-II (IGF2) gene, silencing of the normally active maternal allele of the H19 gene, and aberrant methylation of a differentially methylated region (DMR) upstream of the maternal copy of H19. Recently, the transcription factor CTCF, which binds to the H19 DMR, has been implicated in the maintenance of H19 and IGF2 imprinting. Here, we show that mutations in the CTCF gene or in the H19 DMR do not occur at significant frequency in WT, nor is there transcriptional silencing of CTCF. We also confirm that methylation of the H19 DMR in WT with LOI includes the CTCF core consensus site. However, some WTs with normal imprinting of IGF2 also show aberrant methylation of CTCF binding sites, indicating that methylation of these sites is necessary but not sufficient for LOI in WT.
This article has been cited by other articles:
![]() |
P. J. Beltran, P. Mitchell, Y.-A Chung, E. Cajulis, J. Lu, B. Belmontes, J. Ho, M. M. Tsai, M. Zhu, S. Vonderfecht, et al. AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells Mol. Cancer Ther., May 1, 2009; 8(5): 1095 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. X. Fu, J. R. Dobosy, J. A. Desotelle, N. Almassi, J. A. Ewald, R. Srinivasan, M. Berres, J. Svaren, R. Weindruch, and D. F. Jarrard Aging and Cancer-Related Loss of Insulin-like Growth Factor 2 Imprinting in the Mouse and Human Prostate Cancer Res., August 15, 2008; 68(16): 6797 - 6802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Bjornsson, M. I. Sigurdsson, M. D. Fallin, R. A. Irizarry, T. Aspelund, H. Cui, W. Yu, M. A. Rongione, T. J. Ekstrom, T. B. Harris, et al. Intra-individual Change Over Time in DNA Methylation With Familial Clustering JAMA, June 25, 2008; 299(24): 2877 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cerrato, A. Sparago, G. Verde, A. De Crescenzo, V. Citro, M. V. Cubellis, M. M. Rinaldi, L. Boccuto, G. Neri, C. Magnani, et al. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour Hum. Mol. Genet., May 15, 2008; 17(10): 1427 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Byun, H.-L. Wong, E. A. Birnstein, E. M. Wolff, G. Liang, and A. S. Yang Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer Cancer Res., November 15, 2007; 67(22): 10753 - 10758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Hancock, K. W. Brown, K. Moorwood, H. Moon, C. Holmgren, S. H. Mardikar, A. R. Dallosso, E. Klenova, D. Loukinov, R. Ohlsson, et al. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis Hum. Mol. Genet., February 1, 2007; 16(3): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tost, H. Jammes, J.-M. Dupont, C. Buffat, B. Robert, T.-M. Mignot, F. Mondon, B. Carbonne, U. Simeoni, G. Grange, et al. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region Nucleic Acids Res., November 14, 2006; 34(19): 5438 - 5448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Murphy, Z. Huang, Y. Wen, M. A. Spillman, R. S. Whitaker, L. R. Simel, T. D. Nichols, J. R. Marks, and A. Berchuck Frequent IGF2/H19 Domain Epigenetic Alterations and Elevated IGF2 Expression in Epithelial Ovarian Cancer Mol. Cancer Res., April 1, 2006; 4(4): 283 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Waterland, J.-R. Lin, C. A. Smith, and R. L. Jirtle Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus Hum. Mol. Genet., March 1, 2006; 15(5): 705 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. West and P. Fraser Remote control of gene transcription Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R101 - R111. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Prawitt, T. Enklaar, B. Gartner-Rupprecht, C. Spangenberg, M. Oswald, E. Lausch, P. Schmidtke, D. Reutzel, S. Fees, R. Lucito, et al. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor PNAS, March 15, 2005; 102(11): 4085 - 4090. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. X. Fu, S. R. Schwarze, M. L. Kenowski, S. LeBlanc, J. Svaren, and D. F. Jarrard A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells J. Biol. Chem., December 10, 2004; 279(50): 52218 - 52226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T.C. Chan, Q. Tao, K. D. Robertson, I. W. Flinn, R. B. Mann, B. Klencke, W. H. Kwan, T. W.-T. Leung, P. J. Johnson, and R. F. Ambinder Azacitidine Induces Demethylation of the Epstein-Barr Virus Genome in Tumors J. Clin. Oncol., April 15, 2004; 22(8): 1373 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ulaner, Y. Yang, J.-F. Hu, T. Li, T. H. Vu, and A. R. Hoffman CTCF Binding at the Insulin-Like Growth Factor-II (IGF2)/H19 Imprinting Control Region Is Insufficient to Regulate IGF2/H19 Expression in Human Tissues Endocrinology, October 1, 2003; 144(10): 4420 - 4426. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ulaner, T. H. Vu, T. Li, J.-F. Hu, X.-M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi, et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site Hum. Mol. Genet., March 1, 2003; 12(5): 535 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishizaki, M. Yoshie, Y. Yaginuma, T. Tanaka, and K. Ogawa Loss of Igf2 Imprinting in Monoclonal Mouse Hepatic Tumor Cells Is Not Associated with Abnormal Methylation Patterns for the H19, Igf2, and Kvlqt1 Differentially Methylated Regions J. Biol. Chem., February 14, 2003; 278(8): 6222 - 6228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Tam, T. R. Devereux, A. C. Patel, J. F. Foley, R. R. Maronpot, and T. E. Massey Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors Carcinogenesis, January 1, 2003; 24(1): 121 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cui, P. Onyango, S. Brandenburg, Y. Wu, C.-L. Hsieh, and A. P. Feinberg Loss of Imprinting in Colorectal Cancer Linked to Hypomethylation of H19 and IGF2 Cancer Res., November 15, 2002; 62(22): 6442 - 6446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Feinberg, M. Oshimura, and J. C. Barrett Epigenetic Mechanisms in Human Disease Cancer Res., November 15, 2002; 62(22): 6784 - 6787. [Full Text] [PDF] |
||||
![]() |
C. Kanduri, M. Kanduri, L. Liu, N. Thakur, S. Pfeifer, and R. Ohlsson The Kinetics of Deregulation of Expression by de Novo Methylation of the H19 Imprinting Control Region in Cancer Cells Cancer Res., August 15, 2002; 62(16): 4545 - 4548. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Onyango, S. Jiang, H. Uejima, M. J. Shamblott, J. D. Gearhart, H. Cui, and A. P. Feinberg Monoallelic expression and methylation of imprinted genes in human and mouse embryonic germ cell lineages PNAS, August 6, 2002; 99(16): 10599 - 10604. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Gao, S. Suppola, J. Liu, P. Heikkila, J. Janne, and R. Voutilainen Association of H19 Promoter Methylation with the Expression of H19 and IGF-II Genes in Adrenocortical Tumors J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1170 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Stimson and P. M. Vertino Methylation-mediated Silencing of TMS1/ASC Is Accompanied by Histone Hypoacetylation and CpG Island-localized Changes in Chromatin Architecture J. Biol. Chem., February 8, 2002; 277(7): 4951 - 4958. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Davies, L. Bowden, P. Smith, W. Dean, D. Hill, H. Furuumi, H. Sasaki, B. Cattanach, and W. Reik Disruption of mesodermal enhancers for Igf2 in the minute mutant Development, January 4, 2002; 129(7): 1657 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Schneider, A. E. Schuster, M. K. Fritsch, J. Hu, T. Olson, S. Lauer, U. Gobel, and E. J. Perlman Multipoint Imprinting Analysis Indicates a Common Precursor Cell for Gonadal and Nongonadal Pediatric Germ Cell Tumors Cancer Res., October 1, 2001; 61(19): 7268 - 7276. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |